Pharma scores high for diversity

Six pharmaceutical companies have featured in this year’s DiversityInc Top 50 Companies for Diversity.

In order of appearance these include Johnson & Johnson (6th), Merck & Co (15th), Novartis (21st), Abbott (24th), Procter & Gamble (25th) and Eli Lilly (39th).

Johnson & Johnson was commended for it exceptional work/life benefits and variety of mentoring programs, leadership-development programs and other initiatives for personal and professional growth.

William C. Weldon, Chairman and CEO (pictured), said: “The principles of diversity and inclusion are rooted in Our Credo and serve as critical business enablers for the Johnson & Johnson Family of Companies. We understand that winning in diversity and inclusion allows us to attract superior talent and drive extraordinary outcomes for our patients and customers.”

The company was also placed in the Top 50 Companies for Executive Women, along with Procter & Gamble, the board of directors of which is 36% women. Procter & Gamble was also judged to be the top company for global cultural competence.

Although it did not feature in the top 50, Pfizer was found to be the top company for working families. It featured alongside Boehringer Ingelheim in DiversityInc’s list of ‘noteworthy companies’.